Trial Profile
Serial observation of everolimus-eluting stent incomplete stent apposition by frequency domain optical coherence tomography
Status:
Completed
Phase of Trial:
Clinical Phase Unknown
Latest Information Update: 20 Oct 2015
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Coronary artery disease; Coronary artery restenosis
- Focus Adverse reactions
- Acronyms OPUS-CLASS Cohort B
- 20 Oct 2015 New trial record
- 02 Sep 2015 Results presented at ESC Congress 2015: Annual Congress of the European Society of Cardiology.